CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer
出版年份 2021 全文链接
标题
CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer
作者
关键词
-
出版物
Scientific Reports
Volume 11, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-03-16
DOI
10.1038/s41598-021-85379-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- 2-Substituted α,β-Methylene-ADP Derivatives: Potent Competitive Ecto-5′-nucleotidase (CD73) Inhibitors with Variable Binding Modes
- (2020) Sanjay Bhattarai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pembrolizumab for Early Triple-Negative Breast Cancer
- (2020) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression
- (2020) Charlotte Levin Tykjær Jørgensen et al. BREAST CANCER RESEARCH AND TREATMENT
- Compartmentalization of adenosine metabolism in cancer cells and its modulation during acute hypoxia
- (2020) Karolina Losenkova et al. JOURNAL OF CELL SCIENCE
- CD73 promotes tumor metastasis by modulating RICS/RhoA signaling and EMT in gastric cancer
- (2020) Zhijun Xu et al. Cell Death & Disease
- CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers
- (2020) Jerry B. Harvey et al. Frontiers in Immunology
- Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ecto-Nucleotidases CD73 and CD39
- (2020) Jenna L. Jeffrey et al. JOURNAL OF MEDICINAL CHEMISTRY
- The ARRIVE guidelines 2.0: updated guidelines for reporting animal research
- (2020) Nathalie Percie du Sert et al. JOURNAL OF PHYSIOLOGY-LONDON
- The adenosine pathway in immuno-oncology
- (2020) Bertrand Allard et al. Nature Reviews Clinical Oncology
- Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups
- (2019) Oscar M. Rueda et al. NATURE
- A Novel Specific Anti-CD73 Antibody Inhibits Triple-Negative Breast Cancer Cell Motility by Regulating Autophagy
- (2019) Zheng Qiao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Highly‐expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β‐catenin and mTOR/HIF1α/VEGF signaling
- (2019) Yingchi Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Blockade pf CD73/adenosine axis improves the therapeutic efficacy of docetaxel in epithelial ovarian cancer
- (2019) Hongmei Li et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis
- (2019) Xiao-Lu Ma et al. Journal of Hematology & Oncology
- Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy
- (2019) Simone de Leve et al. Frontiers in Immunology
- Adenosine Metabolism: Emerging Concepts for Cancer Therapy
- (2019) Detlev Boison et al. CANCER CELL
- Chemotherapy induces enrichment of CD47+/CD73+/PDL1+immune evasive triple-negative breast cancer cells
- (2018) Debangshu Samanta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Stretching Reduces Tumor Growth in a Mouse Breast Cancer Model
- (2018) L. Berrueta et al. Scientific Reports
- Identification of allosteric inhibitors of the ecto-5'-nucleotidase (CD73) targeting the dimer interface
- (2018) Rahila Rahimova et al. PLoS Computational Biology
- The A2B Adenosine Receptor Modulates the Epithelial– Mesenchymal Transition through the Balance of cAMP/PKA and MAPK/ERK Pathway Activation in Human Epithelial Lung Cells
- (2018) Chiara Giacomelli et al. Frontiers in Pharmacology
- CD73 Regulates Stemness and Epithelial-Mesenchymal Transition in Ovarian Cancer-Initiating Cells
- (2018) Michela Lupia et al. Stem Cell Reports
- Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq
- (2018) Mihriban Karaayvaz et al. Nature Communications
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- P2Y2 receptor promotes the migration and invasion of breast cancer cells via EMT-related genes Snail and E-cadherin
- (2017) Ying Qiu et al. ONCOLOGY REPORTS
- QuPath: Open source software for digital pathology image analysis
- (2017) Peter Bankhead et al. Scientific Reports
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- Nucleotides and nucleoside signaling in the regulation of the epithelium to mesenchymal transition (EMT)
- (2016) A. S. Martínez-Ramírez et al. Purinergic Signalling
- The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes
- (2016) Bernard Pereira et al. Nature Communications
- CD73 is associated with poor prognosis in HNSCC
- (2016) Zhen-Hu Ren et al. Oncotarget
- α,β-Methylene-ADP (AOPCP) Derivatives and Analogues: Development of Potent and Selective ecto-5′-Nucleotidase (CD73) Inhibitors
- (2015) Sanjay Bhattarai et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Clinical Importance of Assessing Tumor Hypoxia: Relationship of Tumor Hypoxia to Prognosis and Therapeutic Opportunities
- (2014) Joseph C. Walsh et al. ANTIOXIDANTS & REDOX SIGNALING
- Enzymes involved in metabolism of extracellular nucleotides and nucleosides: Functional implications and measurement of activities
- (2014) Gennady G. Yegutkin CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Quantification of Dynamic Morphological Drug Responses in 3D Organotypic Cell Cultures by Automated Image Analysis
- (2014) Ville Härmä et al. PLoS One
- Anti-CD73 therapy impairs tumor angiogenesis
- (2013) Bertrand Allard et al. INTERNATIONAL JOURNAL OF CANCER
- CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer
- (2013) S. Loi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD39 and CD73 in immunity and inflammation
- (2013) Luca Antonioli et al. TRENDS IN MOLECULAR MEDICINE
- Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features
- (2012) A. K. Azab et al. BLOOD
- Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer
- (2012) Johanna Tuomela et al. BREAST CANCER RESEARCH AND TREATMENT
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
- (2012) Christina Curtis et al. NATURE
- Fiji: an open-source platform for biological-image analysis
- (2012) Johannes Schindelin et al. NATURE METHODS
- Cellular function and molecular structure of ecto-nucleotidases
- (2012) Herbert Zimmermann et al. Purinergic Signalling
- CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice
- (2011) Long Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- A Comprehensive Panel of Three-Dimensional Models for Studies of Prostate Cancer Growth, Invasion and Drug Responses
- (2010) Ville Härmä et al. PLoS One
- Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
- (2010) J. Stagg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypoxia, Snail and incomplete epithelial–mesenchymal transition in breast cancer
- (2009) K Lundgren et al. BRITISH JOURNAL OF CANCER
- Hypoxia in microscopic tumors
- (2008) Xiao-Feng Li et al. CANCER LETTERS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now